Nutriband (NASDAQ:NTRBW) Shares Down 3.7% – Here’s What Happened

Nutriband Inc. (NASDAQ:NTRBW)’s stock price traded down 3.7% during trading on Monday . The company traded as low as $1.21 and last traded at $1.30. 1,200 shares traded hands during trading, a decline of 56% from the average session volume of 2,735 shares. The stock had previously closed at $1.35.

Nutriband Price Performance

The stock’s 50 day moving average is $1.53 and its two-hundred day moving average is $1.65.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Nutriband stock. Empery Asset Management LP acquired a new position in shares of Nutriband Inc. (NASDAQ:NTRBW) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 40,218 shares of the company’s stock, valued at approximately $65,000. Nutriband makes up 0.1% of Empery Asset Management LP’s holdings, making the stock its 20th biggest holding.

About Nutriband

Nutriband Inc develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. The company also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility.